A Phase II Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Bevacizumab (Primary) ; Everolimus (Primary)
- Indications Meningioma
- Focus Therapeutic Use
- 03 Jun 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 06 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2014 Planned End Date changed from 1 Nov 2014 to 1 Dec 2014, as per ClinicalTrials.gov record.